- Drugs
- Monday, 04 May 2020
Pharmaceutics International Selected as A Winner of Two GH&P Awards
Pharmaceutics International, Inc. (Pii), a US-based Contract Development and Manufacturing Organization (CDMO) today announced it has won the 2020 CDMO Leadership Award and was named the Most Innovative Company in Dosage Solutions by Global Health & Pharma Magazine.
"We are honored to be recognized in these two categories. Pii has an extensive range of technologies, skilled personnel and Pharmaceutics Know-How™, to enable the rapid development and reliable production of high-quality sterile and oral dosage forms. It is extremely gratifying to have our innovation, accomplishments and commitment to partners and patients acknowledged," said Dr. Kurt R. Nielsen, Pii's President and CEO.
According to GH&P, "Biotechnology is a huge, varied and ever-growing industry. Operating and succeeding in such an environment which, in many ways, demands excellence at every turn is - it goes without saying - incredibly difficult, yet there are businesses that have learned to thrive under such conditions. To harness innovation and deliver results, driving the greater industry onwards." Jazmin Collins, GH&P Awards Coordinator, commented "Regardless of their size or location, we honor companies from across this vibrant and talented sector."
Related Industry Updates
Parenteral Nutrition Market is expected to reach US$ 11.12 billion by 2030
Feb 01, 2024
Vaccine Adjuvant Market is expected to reach US$ 6,931.55 million by 2030
Jan 09, 2024
Hospital Acquired Infection Treatment Market is expected to reach US$ 19,978.39 million by 2030
Dec 11, 2023
Radioactive Tracer Market is expected to reach US$ 54,296.57 million by 2030
Aug 11, 2023
Pharmaceutical Contract Sales Organizations Market is expected to reach US$ 15,820.86 million by 2030
Oct 11, 2023
China Transmucosal Drug Delivery Systems Market 2020: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2027
Dec 03, 2020
Paracetamol Market is expected to reach US$ 14,254.44 million by 2030
Feb 02, 2024